Course Description:
This webinar will cover specifications for Dissolution Performance Verification Standard – Prednisone Reference Standards (DPVS-Prednisone RS) that were developed and the benefits of the new standard, such as less sensitive to media degassing, low tablet-to-tablet variability, and delivering more consistent results for App 1 and App 2. The DPVS – Prednisone Reference Standard became official May 1, 2023, as indicated in the USP General Chapter <711>. The new formulation helps address the challenges faced by industry and ensures the users confidence in the overall dissolution system suitability.
Who should participate:
- Dissolution Instrument manufacturers
- QA/QC
- R&D
- CROs
- Pharma manufacturers
- Dissolution service providers
The live version of this recording took place on August 13, 2024.
Access Duration:
Access to this course expires 60 days from the date of registration or until you mark the course ‘Complete’ – whichever occurs first.
Speaker
Mark R. Liddell, Ph.D.
Manager, Dosage Form Performance Laboratory
USP Employee
Ph.D., Pharmaceutics and Pharmaceutical Chemistry, University of Utah